Showing results (161-170 of 175) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.The Journal of Organic Chemistry|November 1, 2023
Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467Patrick B Brady, Bryan K Sorensen, Roberto M Risi, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinasesMichael L Curtin, H Robin Heyman, Robin R Frey, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Alpha-keto amides as inhibitors of histone deacetylaseCarol K Wada, Robin R Frey, Zhiqin Ji, et al.Journal of Medicinal Chemistry|January 5, 2002
Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitorsCarol K Wada, James H Holms, Michael L Curtin, et al.Bioorganic & Medicinal Chemistry Letters|March 4, 2017
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED bindingMichael L Curtin, Marina A Pliushchev, Huan-Qiu Li, et al.Journal of Medicinal Chemistry|January 23, 1998
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonistsM L Curtin, S K Davidsen, H R Heyman, et al.Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.Pageof 18